Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrotic Syndrome | 18 | 2021 | 373 | 5.990 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 9 | 2021 | 332 | 2.900 |
Why?
|
| Kidney Glomerulus | 5 | 2019 | 717 | 1.460 |
Why?
|
| Genomics | 10 | 2021 | 4921 | 1.440 |
Why?
|
| Urinary Tract | 5 | 2019 | 282 | 1.330 |
Why?
|
| Kidney | 11 | 2021 | 6744 | 1.010 |
Why?
|
| Alleles | 10 | 2021 | 7140 | 0.880 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2021 | 1730 | 0.840 |
Why?
|
| Nephrology | 2 | 2020 | 216 | 0.810 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 45 | 0.810 |
Why?
|
| Kidney Diseases | 6 | 2021 | 2099 | 0.800 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 215 | 0.690 |
Why?
|
| Genetic Testing | 4 | 2020 | 3230 | 0.640 |
Why?
|
| Podocytes | 4 | 2021 | 408 | 0.620 |
Why?
|
| Access to Information | 1 | 2019 | 314 | 0.610 |
Why?
|
| African Americans | 4 | 2018 | 5144 | 0.540 |
Why?
|
| Apolipoproteins | 1 | 2015 | 293 | 0.510 |
Why?
|
| Kidney Tubules | 1 | 2015 | 534 | 0.490 |
Why?
|
| Genetics, Population | 2 | 2015 | 1001 | 0.490 |
Why?
|
| Quantitative Trait Loci | 3 | 2021 | 1953 | 0.480 |
Why?
|
| Microfluidics | 1 | 2016 | 541 | 0.450 |
Why?
|
| Genotype | 12 | 2021 | 13073 | 0.430 |
Why?
|
| Genetic Variation | 6 | 2021 | 6772 | 0.430 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 622 | 0.420 |
Why?
|
| Hirschsprung Disease | 1 | 2010 | 142 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2010 | 333 | 0.380 |
Why?
|
| Selection, Genetic | 1 | 2013 | 907 | 0.360 |
Why?
|
| Nephrosis, Lipoid | 2 | 2021 | 47 | 0.360 |
Why?
|
| Premature Birth | 1 | 2017 | 1307 | 0.350 |
Why?
|
| Sequence Deletion | 2 | 2015 | 1585 | 0.320 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3557 | 0.320 |
Why?
|
| Genome-Wide Association Study | 11 | 2021 | 11019 | 0.320 |
Why?
|
| Software | 3 | 2020 | 4314 | 0.300 |
Why?
|
| Proteinuria | 3 | 2019 | 609 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2021 | 15296 | 0.280 |
Why?
|
| Ubiquitins | 2 | 2018 | 417 | 0.280 |
Why?
|
| DNA Copy Number Variations | 3 | 2019 | 1770 | 0.280 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 381 | 0.260 |
Why?
|
| Glomerular Filtration Rate | 4 | 2019 | 2037 | 0.240 |
Why?
|
| Phenotype | 8 | 2018 | 16091 | 0.210 |
Why?
|
| Child | 14 | 2021 | 71361 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17071 | 0.200 |
Why?
|
| Humans | 45 | 2021 | 686663 | 0.200 |
Why?
|
| Urogenital Abnormalities | 2 | 2018 | 222 | 0.200 |
Why?
|
| Age of Onset | 2 | 2017 | 3373 | 0.200 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 107 | 0.190 |
Why?
|
| Genetics, Medical | 1 | 2020 | 323 | 0.180 |
Why?
|
| Membrane Proteins | 6 | 2021 | 8262 | 0.170 |
Why?
|
| HLA-DQ Antigens | 1 | 2018 | 244 | 0.170 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2017 | 36 | 0.170 |
Why?
|
| Diacylglycerol Kinase | 1 | 2017 | 47 | 0.170 |
Why?
|
| Steroids | 2 | 2020 | 830 | 0.160 |
Why?
|
| Haplotypes | 3 | 2021 | 2913 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 3006 | 0.160 |
Why?
|
| HLA-DR Antigens | 1 | 2018 | 729 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 407 | 0.150 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2015 | 19 | 0.150 |
Why?
|
| Chemokine CXCL11 | 1 | 2015 | 43 | 0.150 |
Why?
|
| Chemokine CXCL9 | 1 | 2015 | 127 | 0.150 |
Why?
|
| Chromosome Deletion | 2 | 2018 | 1385 | 0.150 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2018 | 418 | 0.150 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 175 | 0.150 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 289 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2722 | 0.140 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 188 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 934 | 0.140 |
Why?
|
| Adolescent | 8 | 2018 | 84957 | 0.140 |
Why?
|
| Young Adult | 6 | 2018 | 56052 | 0.130 |
Why?
|
| Pedigree | 2 | 2019 | 4792 | 0.130 |
Why?
|
| Fetal Development | 1 | 2019 | 729 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2021 | 1925 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2021 | 41159 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 699 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 749 | 0.120 |
Why?
|
| Introns | 1 | 2015 | 1055 | 0.120 |
Why?
|
| Case-Control Studies | 7 | 2019 | 21684 | 0.120 |
Why?
|
| Mucins | 1 | 2015 | 538 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 5044 | 0.120 |
Why?
|
| Reference Values | 2 | 2016 | 5134 | 0.120 |
Why?
|
| Adult | 11 | 2021 | 211400 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2018 | 1848 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 381 | 0.110 |
Why?
|
| Atrophy | 1 | 2015 | 1447 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2015 | 487 | 0.110 |
Why?
|
| Genes, Recessive | 1 | 2013 | 673 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2021 | 38732 | 0.110 |
Why?
|
| Biopsy | 4 | 2015 | 6849 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2019 | 2922 | 0.100 |
Why?
|
| Female | 18 | 2021 | 375459 | 0.100 |
Why?
|
| Ear | 1 | 2010 | 179 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2019 | 23953 | 0.100 |
Why?
|
| Point Mutation | 1 | 2015 | 1707 | 0.100 |
Why?
|
| Mutation | 4 | 2020 | 28848 | 0.100 |
Why?
|
| Gene Frequency | 1 | 2016 | 3713 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2019 | 2575 | 0.090 |
Why?
|
| Exons | 1 | 2015 | 2519 | 0.090 |
Why?
|
| Fibrosis | 1 | 2015 | 1798 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 2467 | 0.090 |
Why?
|
| Male | 17 | 2021 | 352465 | 0.090 |
Why?
|
| Prognosis | 5 | 2020 | 28923 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2570 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1818 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6464 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2019 | 4314 | 0.080 |
Why?
|
| Internet | 2 | 2016 | 3097 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15407 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9661 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2839 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4015 | 0.070 |
Why?
|
| Risk Factors | 5 | 2019 | 69278 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3972 | 0.070 |
Why?
|
| Risk | 1 | 2016 | 9915 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4132 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3285 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 216468 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13603 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2021 | 1137 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4415 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19308 | 0.060 |
Why?
|
| Zebrafish | 3 | 2019 | 2969 | 0.060 |
Why?
|
| Hypertension | 1 | 2021 | 7941 | 0.060 |
Why?
|
| Gene Expression | 1 | 2015 | 8182 | 0.060 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 10 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 6009 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 4129 | 0.050 |
Why?
|
| Genome, Human | 1 | 2013 | 4458 | 0.050 |
Why?
|
| United States | 2 | 2017 | 65579 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13469 | 0.050 |
Why?
|
| Africa, Northern | 1 | 2018 | 66 | 0.050 |
Why?
|
| Lithuania | 1 | 2017 | 24 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 49071 | 0.040 |
Why?
|
| Clathrin | 1 | 2019 | 264 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 164 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 379 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 832 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8896 | 0.040 |
Why?
|
| France | 1 | 2018 | 492 | 0.040 |
Why?
|
| Spain | 1 | 2018 | 468 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 5835 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 1005 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 805 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 348 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 803 | 0.040 |
Why?
|
| Cell Movement | 2 | 2019 | 5671 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 615 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 963 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 1858 | 0.040 |
Why?
|
| Base Composition | 1 | 2015 | 321 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 2015 | 398 | 0.040 |
Why?
|
| Probability | 1 | 2020 | 2508 | 0.040 |
Why?
|
| Endocytosis | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2020 | 6120 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 760 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 1026 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 323 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2016 | 452 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 2101 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1717 | 0.030 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2013 | 71 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 1855 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1363 | 0.030 |
Why?
|
| Remission Induction | 1 | 2015 | 2387 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 2035 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2787 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 563 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 59331 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2263 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1169 | 0.020 |
Why?
|
| India | 1 | 2015 | 2196 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2019 | 3982 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 500 | 0.020 |
Why?
|
| Animals | 5 | 2019 | 170849 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4297 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2021 | 3987 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 80803 | 0.020 |
Why?
|
| Regeneration | 1 | 2015 | 1556 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 162271 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1799 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 33918 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1586 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2021 | 8529 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10926 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 17137 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 15597 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 10094 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 10261 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12525 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 23439 | 0.010 |
Why?
|
| Proteins | 1 | 2015 | 6264 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 7791 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13500 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 20620 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13204 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 20496 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 25703 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11833 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23739 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13444 | 0.010 |
Why?
|
| Registries | 1 | 2013 | 8033 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 24351 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 19295 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 10088 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 42271 | 0.010 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_